Latest Stories
UnitedHealth (UNH): Buy, Sell, or Hold Post Q3 Earnings?
UnitedHealth has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 14.5% to $344.03 per share while the index has gained 10.4%.
3 Reasons to Sell IQV and 1 Stock to Buy Instead
What a time it’s been for IQVIA. In the past six months alone, the company’s stock price has increased by a massive 51.4%, reaching $242.50 per share. This performance may have investors wondering how to approach the situation.
3 Reasons to Avoid PB and 1 Stock to Buy Instead
Prosperity Bancshares has been treading water for the past six months, recording a small loss of 2.7% while holding steady at $72.51. The stock also fell short of the S&P 500’s 10.4% gain during that period.
3 Reasons to Avoid IR and 1 Stock to Buy Instead
Ingersoll Rand has been treading water for the past six months, recording a small loss of 2.4% while holding steady at $85.51. The stock also fell short of the S&P 500’s 10.4% gain during that period.
2 Reasons to Watch GEV and 1 to Stay Cautious
GE Vernova trades at $622.75 per share and has stayed right on track with the overall market, gaining 12.2% over the last six months. At the same time, the S&P 500 has returned 10.4%.
Altria (MO): Buy, Sell, or Hold Post Q3 Earnings?
Altria currently trades at $57.49 per share and has shown little upside over the past six months, posting a small loss of 1.1%. The stock also fell short of the S&P 500’s 10.4% gain during that period.
3 Reasons to Sell SSTK and 1 Stock to Buy Instead
Since July 2025, Shutterstock has been in a holding pattern, posting a small return of 3.7% while floating around $19.54. The stock also fell short of the S&P 500’s 10.4% gain during that period.
The Real Brokerage (REAX): Buy, Sell, or Hold Post Q3 Earnings?
The Real Brokerage currently trades at $4.20 per share and has shown little upside over the past six months, posting a middling return of 3.4%. The stock also fell short of the S&P 500’s 10.4% gain during that period.
2 Reasons to Like JKHY and 1 to Stay Skeptical
Jack Henry has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.4% to $189.14 per share while the index has gained 10.4%.
3 Reasons ACM is Risky and 1 Stock to Buy Instead
Over the last six months, AECOM’s shares have sunk to $99.63, producing a disappointing 13% loss - a stark contrast to the S&P 500’s 10.4% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.